Image For Activity Cover
Feasibility and Safety of Intravenous Sotalol to Initiate Oral Sotalol Therapy in Atrial Fibrillation (DASH-AF) - JCEP April 2023
Description
The DASH-AF trial shows that rapid IV sotalol loading in atrial fibrillation/flutter patients for rhythm control is feasible and safe compared with conventional oral loading with significant cost reduction. (Feasibility and Safety of Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients With Atrial Fibrillation [DASH-AF]).

Editor-in-Chief
Kalyanam Shivkumar, MD, PhD, FACC 

CME Editor
Kenneth A. Ellenbogen, MD, FACC

Author
Kelvin Bush, MD, FACC

Important Dates
Date of Release: April 24, 2023
Term of Approval/Date of CME/MOC Expiration: April 23, 2024
Summary
Availability: On-Demand
Expires on Apr 23, 2024
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
Android App Download IOS App Download Powered By